Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines (2016) Schmitz-Draeger BJ, Kuckuck EC, Zuiverloon TCM, Zwarthoff EC, Saltzman A, Srivastava A, Hudson MA, et al. Journal article Assessing the quality of studies on the diagnostic accuracy of tumor markers (2014) Goebell P, Kamat AM, Sylvester RJ, Black P, Droller M, Godoy G, Hudson MA, et al. Journal article Molecular markers for urothelial bladder cancer prognosis: toward implementation in clinical practice (2014) van Rhijn BWG, Catto JW, Goebell P, Knuechel R, Shariat SF, Van Der Poel HG, Sanchez-Carbayo M, et al. Journal article Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer (2014) Kamat AM, Vlahou A, Taylor JA, Hudson MA, Pesch B, Ingersoll MA, Todenhöfer T, et al. Journal article A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study (2014) Goebell P, Muench A, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N Journal article Current concepts--future needs: the 10th Annual Meeting of the International Bladder Cancer Network (IBCN) in Nijmegen, The Netherlands, September 20th to 22nd, 2012 (2014) Nawroth R, Goebell PJ, Kamat AM, Kiemeney LA, Schmitz-Draeger BJ Journal article, Note Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma (2014) Keck B, Elhnann C, Stoehr R, Weigelt K, Goebell P, Kunath F, Taubert H, et al. Journal article